Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | MRNA |
|---|---|---|
| Return | ||
| Last Price | 54.70 | 145.00 |
| Daily Change | — | − 2.60% |
| Period ReturnPast 6 Months | — | + 171.70% |
| Valuation | ||
| Market Cap | $4.50 B | $57.5 B |
| P/E Ratio | — | — |
| Dividend Yield | — | — |
| Net MarginTrailing 12M | — | 141.4% |
| Risk | ||
| Beta | — | 1.22 |
| 52-Week Range | — | 22.28 — $176.66 |
| Company | ||
| Sector | — | Health Care |
| Industry | Biotechnology | Biotechnology |
Company
- AKROBiotechnology
- MRNAHealth Care · Biotechnology
Metrics could not be loaded for AKRO: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 02:5915 Minutes Delayed
To Understand This